Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Müllerian anomalies.

Lee P Shulman1

  • 1The Anna Ross Lapham Professor in Obstetrics and Gynecology, Department of Obstetrics and Gynecology, Feinberg School of Medicine, Northwestern University, NMH/Prentice Women's Hospital, Chicago, Illinois, USA. lshulman@nmh.org

Clinical Obstetrics and Gynecology
|May 9, 2008
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Comparative Efficacy of Elinzanetant Versus Other Non-Hormonal Pharmaceutical Therapies for the Treatment of Moderate-to-Severe Vasomotor Symptoms Associated With Menopause: A Network Meta-Analysis.

BJOG : an international journal of obstetrics and gynaecology·2026
Same author

Efficacy and safety of casirivimab/imdevimab (REGEN-COV) in pregnant individuals with COVID-19: Literature review and insights from the COVID-19 International Drug Pregnancy Registry.

Obstetric medicine·2025
Same author

Why does the latest pharmacovigilance data not reflect clinical experience with dydrogesterone?

Human reproduction open·2025
Same author

Clinical Evaluation of Effectiveness and Safety of Combined Use of Dietary Supplements Amberen<sup>®</sup> and Smart B<sup>®</sup> in Women with Climacteric Syndrome in Perimenopause.

Advances in therapy·2024
Same author

Use of Sotrovimab in Pregnancy: Experiences from the COVID-19 International Drug Pregnancy Registry.

Drug safety·2024
Same author

No additional risk of congenital anomalies after first-trimester dydrogesterone use: a systematic review and meta-analysis.

Human reproduction open·2024
Same journal

Obstetric Care for Patients With Cognitive Disabilities.

Clinical obstetrics and gynecology·2026
Same journal

Dissecting the Americans With Disabilities Act (ADA) Requirements when Approaching Obstetric Patients With Disabilities: How to Ensure Your Spaces are Accessible for All.

Clinical obstetrics and gynecology·2026
Same journal

Clinician Comfort and Barriers to the Obstetric and Gynecologic Care of Patients With Disabilities.

Clinical obstetrics and gynecology·2026
Same journal

Obstetric Care for Patients With Visual Impairments: Preconception Counseling Through Postpartum Care.

Clinical obstetrics and gynecology·2026
Same journal

Menstrual Management and Contraception for Patients With Disabilities.

Clinical obstetrics and gynecology·2026
Same journal

Favoring Elective Hospitalization in Pregnancies With Vasa Previa.

Clinical obstetrics and gynecology·2026
See all related articles

Müllerian anomalies, though uncommon, can cause significant gynecologic, fertility, and obstetrical problems. Early suspicion and appropriate counseling are vital for managing these conditions and supporting reproductive health.

Area of Science:

  • Reproductive Medicine
  • Gynecology
  • Embryology

Background:

  • Müllerian anomalies are congenital abnormalities of the female reproductive tract.
  • Their exact incidence is challenging to determine.
  • These anomalies can impact gynecologic, fertility, and obstetrical health.

Purpose of the Study:

  • To highlight the clinical significance of Müllerian anomalies.
  • To emphasize the importance of recognizing associated symptoms.
  • To discuss management and counseling needs.

Main Methods:

  • Literature review on Müllerian anomalies.
  • Clinical case analysis.
  • Discussion of diagnostic indicators.

Main Results:

Related Experiment Videos

  • Müllerian anomalies are linked to primary amenorrhea, pelvic pain, and recurrent pregnancy loss.
  • Adverse obstetrical outcomes are also associated with these anomalies.
  • Many women can achieve good reproductive outcomes with proper management.

Conclusions:

  • Clinicians should maintain a high index of suspicion for Müllerian anomalies in specific clinical scenarios.
  • Psychological counseling is crucial for patients, particularly those with severe anomalies affecting fertility or sexual function.
  • Comprehensive patient care involves addressing both physical and psychological needs.